1217751

Samsung Bioepis Co., Ltd. — FEI 3010031951

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 15, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Yeonsu (Korea (the Republic of))

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors
909921 CFR 600.80(c)(1)(iii)Reporting Requirements - submission of reports